#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Ewing's sarcoma metastatic Ichthyosis Phenylketonuria Epilepsy Glioblastoma Liver abscess Uveal melanoma Non-small cell lung cancer recurrent Piriformis syndrome Heart disease congenital Ischaemic stroke Glomerulonephritis membranous Small cell lung cancer limited stage Leukaemia Colon cancer More trials…

    Learn about Rare Diseases

    Congenital hypotransferrinaemia – Basic Information Pleomorphic leiomyosarcoma Myxofibrosarcoma – Trials in Disease Urea cycle disorder – Life with Disease Adrenogenital syndrome – Treatment Pulmonary sarcoidosis – Basic Information Cholangitis sclerosing – Basic Information Krabbe’s disease – Basic Information Acute respiratory distress syndrome – Trials in Disease Acquired haemophilia – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    ANOC-001 Bempikibart Dipyridamole Zoledronic Acid LUNRESERTIB Lufepirsen Sucrose Azilsartan Medoxomil Other Blood Products Gad20-209-Fsp-A3 Mirikizumab HSP-CAR30 Fedratinib Verapamil ANERATRIGINE MESILATE Hydroxyzine Hydrochloride Lucerastat Enlicitide Chloride Cenobamate Mometasone Furoate Monohydrate More therapies…

    Learn about Your Condition

    Barrett's oesophagus Mechanical ventilation Plasma cell myeloma refractory Foetal growth restriction Red blood cell abnormality Melanoma recurrent Elderly Asthma Follicular lymphoma stage III Anxiety disorder Ischaemic skin ulcer Intestinal obstruction Vascular dementia Craniocerebral injury Connective tissue disorder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Chronic graft versus host disease

  • Study of Axatilimab for Patients with Chronic Graft Versus Host Disease After Two Prior Treatments

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Chronic graft versus host disease
    Investigated Drugs:
    • Axatilimab
    Belgium France Germany Greece Italy Spain

  • Study on Axatilimab and Ruxolitinib for Patients with Newly Diagnosed Chronic Graft-Versus-Host Disease

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Axatilimab
    • Ruxolitinib
    • Methylprednisolone
    Belgium Germany Italy Spain

  • Study on Long-Term Safety of Ruxolitinib, Panobinostat, and Siremadlin for Patients Continuing Treatment from Previous Studies

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Acute graft versus host disease in intestine
    • Acute graft versus host disease in liver
    • Acute graft versus host disease in skin
    Investigated Drugs:
    • Panobinostat
    • Siremadlin
    • Ruxolitinib
    Germany Italy Poland Sweden

  • Study of Belumosudil and Prednisone for Patients Aged 12 and Older with Newly Diagnosed Chronic Graft Versus Host Disease

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Chronic graft versus host disease
    Investigated Drugs:
    • Belumosudil Mesilate
    • Abiraterone Acetate
    • Prednisolone
    Austria Belgium Czechia Denmark France Germany +7

  • Study on the Safety and Effectiveness of Ibrutinib for Children and Young Adults with Chronic Graft Versus Host Disease

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Chronic graft versus host disease
    Investigated Drugs:
    • Ibrutinib
    • Prednisone
    France Germany Italy The Netherlands Spain

  • Continued Treatment Study for Patients with Myelofibrosis, Post-Lung Transplant BOS, or Chronic Graft-Versus-Host Disease Using Itacitinib

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Chronic graft versus host disease
    • Myelofibrosis
    Investigated Drugs:
    • Itacitinib
    Austria Belgium Germany Greece Italy Spain
Previous Page
1 2

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!